Greenwich LifeSciences, Inc. (GLSI) shares are down on Monday morning trade, after reaching an all-time peak last week.
The company shares have spiked as the biopharma company announced zero percent recurrence of breast cancer in its GP2 Phase IIb clinical trial through a poster presentation. On December 09, the shares have reached a high of 158.07.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.